128 related articles for article (PubMed ID: 16834932)
1. Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.
Hou JQ; He J; Wen DG; Chen ZX; Zeng J
Chin Med J (Engl); 2006 Jul; 119(13):1118-20. PubMed ID: 16834932
[No Abstract] [Full Text] [Related]
2. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
Kitsukawa S; Aoyagi T; Noda K; Ito T; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T
Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
[TBL] [Abstract][Full Text] [Related]
5. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
Al-Maghrebi M; Kehinde EO; Kapila K; Anim JT
Med Princ Pract; 2012; 21(3):295-7. PubMed ID: 22236881
[TBL] [Abstract][Full Text] [Related]
6. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma.
Huang YL; Chiu AW; Huan SK; Wang YC; Ju JP; Lu CL
Anticancer Res; 2003; 23(3B):2729-33. PubMed ID: 12894566
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
Xie XY; Yang X; Zhang JH; Liu ZJ
Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
[TBL] [Abstract][Full Text] [Related]
10. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
11. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
[TBL] [Abstract][Full Text] [Related]
12. Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas.
Pina-Cabral L; Santos L; Mesquita B; Amaro T; Magalhães S; Criado B
Clin Transl Oncol; 2007 Nov; 9(11):731-6. PubMed ID: 18055328
[TBL] [Abstract][Full Text] [Related]
13. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
14. Urine detection of survivin and diagnosis of bladder cancer.
Moore M
J Insur Med; 2001; 33(2):202-3. PubMed ID: 11510521
[No Abstract] [Full Text] [Related]
15. Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients.
Selmy MA; Ibrahim GH; El Serafi TI; Ghobeish AA
Cancer Biomark; 2010; 7(3):163-70. PubMed ID: 21263192
[TBL] [Abstract][Full Text] [Related]
16. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
[No Abstract] [Full Text] [Related]
17. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
18. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y
Cancer; 2007 Mar; 109(6):1106-13. PubMed ID: 17311310
[TBL] [Abstract][Full Text] [Related]
19. Considerations on the use of urine markers for bladder cancer.
van Rhijn BW
Eur Urol; 2008 May; 53(5):880-1. PubMed ID: 18222604
[No Abstract] [Full Text] [Related]
20. Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.
Kenney DM; Geschwindt RD; Kary MR; Linic JM; Sardesai NY; Li ZQ
Tumour Biol; 2007; 28(2):57-62. PubMed ID: 17259754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
